ABEONA THERAPEUTICS INC's ticker is ABEO and the CUSIP is 00289Y107. A total of 88 filers reported holding ABEONA THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 1.01 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $228,000 | +20.0% | 121,100 | 0.0% | 0.00% | – |
| Q4 2020 | $190,000 | +53.2% | 121,100 | 0.0% | 0.00% | – |
| Q3 2020 | $124,000 | -67.8% | 121,100 | -8.3% | 0.00% | – |
| Q2 2020 | $385,000 | +151.6% | 132,100 | +81.7% | 0.00% | – |
| Q1 2020 | $153,000 | +25.4% | 72,700 | +94.9% | 0.00% | – |
| Q4 2019 | $122,000 | +45.2% | 37,300 | 0.0% | 0.00% | – |
| Q3 2019 | $84,000 | -73.7% | 37,300 | -44.1% | 0.00% | – |
| Q2 2019 | $319,000 | -24.2% | 66,700 | +16.6% | 0.00% | – |
| Q1 2019 | $421,000 | +3.2% | 57,200 | 0.0% | 0.00% | – |
| Q4 2018 | $408,000 | -34.0% | 57,200 | +18.4% | 0.00% | – |
| Q3 2018 | $618,000 | -20.1% | 48,300 | 0.0% | 0.00% | -100.0% |
| Q2 2018 | $773,000 | +22.5% | 48,300 | +9.8% | 0.00% | – |
| Q1 2018 | $631,000 | +34.5% | 44,000 | +48.6% | 0.00% | – |
| Q4 2017 | $469,000 | +1072.5% | 29,600 | +91.0% | 0.00% | – |
| Q1 2016 | $40,000 | -23.1% | 15,500 | 0.0% | 0.00% | – |
| Q4 2015 | $52,000 | -17.5% | 15,500 | 0.0% | 0.00% | – |
| Q3 2015 | $63,000 | -19.2% | 15,500 | 0.0% | 0.00% | – |
| Q2 2015 | $78,000 | – | 15,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 1,359,767 | $3,209,000 | 1.04% |
| DAFNA Capital Management LLC | 181,818 | $429,000 | 0.34% |
| Perceptive Advisors | 1,762,881 | $4,159,000 | 0.29% |
| NEXTHERA CAPITAL LP | 100,000 | $236,000 | 0.20% |
| SPHERA FUNDS MANAGEMENT LTD. | 138,105 | $326,000 | 0.08% |
| Soros Fund Management | 1,462,122 | $3,451,000 | 0.07% |
| SABBY MANAGEMENT, LLC | 270,000 | $637,000 | 0.03% |
| CAMBRIDGE TRUST CO | 65,414 | $154,000 | 0.01% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 30,000 | $71,000 | 0.01% |
| ROYCE & ASSOCIATES LP | 376,321 | $888,000 | 0.01% |